Search results
Results from the WOW.Com Content Network
On December 3, 2019, Rapt Therapeutics and Hanami Pharmaceutical announced collaboration to develop and commercialize FLX475 in Asia. [13] FLX475 is an oral, small molecule CCR4 antagonist in development for the treatment of multiple cancers. In August 2020, chairman and founder of Hanmi Pharmaceutical Lim Sung-ki died of a chronic disease. He ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
This list is based on the Forbes Global 2000, which ranks the world's 2,000 largest publicly traded companies.The Forbes list takes into account a multitude of factors, including the revenue, net profit, total assets and market value of each company; each factor is given a weighted rank in terms of importance when considering the overall ranking.
In March, Sanofi became the last of three companies that account for 90% of the world's insulin business to announce price cuts. Novo Nordisk and Eli Lilly Co.'s plans had slashed U.S. prices by ...
They agreed to increase the price of the shares in question at the end of certain days' trading, to make the prices look better in clients' portfolios. [ 43 ] Trading in stocks simply to move the market price is a serious abuse: it distorts market forces and undermines investors' confidence in the integrity of the prices quoted on exchanges ...
South Korean drugmaker Daewoong Pharma said on Thursday it had sought regulatory approval for Phase II trials of its anti-parasite niclosamide drug to treat COVID-19 patients, sending its shares ...
Four pharmaceutical companies involved in the first U.S. negotiations over prices for the Medicare program said they do not expect a significant impact on their businesses after seeing ...
Seungpil Yu or Yoo Seung-Pil (Korean: 유승필; Hanja: 柳承弼; born September 23, 1946) is the chairman and CEO of Yuyu Pharma, a South Korean pharmaceutical company that engages in the research, development, manufacture and sales of medicines, vitamins, health foods, medical devices, and cosmetics.